Can a hormone block food cravings? new study investigates
NCT ID NCT06845033
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether infusing a natural hormone called LEAP2 can reduce how the brain reacts to pictures of food in people with obesity. Twenty-eight men with a BMI between 30 and 50 will receive either LEAP2 or a placebo on two separate days and undergo brain scans. The goal is to understand if blocking the ghrelin receptor lowers activity in brain areas linked to appetite and reward.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LEAP2 (a natural hormone that blocks the ghrelin receptor)
- What this could lead to
- If successful, this could point toward a new way to reduce food cravings in obesity by targeting brain appetite centers.
- What could go wrong
- This is a very early, small study (28 men) looking at brain scans, not weight loss. The effect may be small or not translate to real-world eating behavior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Clinical Metabolic Research
Hellerup, 2900, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can timing your carbs tame metabolic risk?
- Home visits may boost heart health for pregnant women in nigeria
- Could a diabetes drug protect obese Teens' hearts?
- Could a biweekly shot rival weekly Weight-Loss drugs?
- Scientists investigate why some bodies fight weight change
- Fasting test may unlock personalized obesity treatment